IJdo JW , Conti-Kelly AM , Greco P et al. Antiphospholipid Antibodies in patients with Multiple Sclerosis and MS-like illnesses: MS or APS?Lupus1998; 8: 109-115 .
2.
Hughes GRV . Personal View: Is it Lupus? The St Thomas' Hospital ‘alternative’ criteria . Clin Exp Rheumatol1998; 16: 250-252 .
3.
Brey R , Gharavi AE , Lockshin MD . Neurologic complications of antiphospholipid antibodies . Rheum Dis Clin North Am1993; 19: 833-850 .
4.
Tourbah A , Clapin A , Gout O et al. Systemic autoimmune features and multiple sclerosis: a 5-year follow-up . Arch Neurol1998; 55: 517-521 .
5.
D'Olhaberriague L , Levine SR , Salowich-Palm L et al. Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS diseases . Neurology1998; 51(S): 1376-1380 .
6.
Fukazawa T , Moriwaka F , Mukai M , Koike T , Tashiro K . Anticardiolipin antibodies in Japanese patients with multiple sclerosis . Acta Neurol Scand1993; 88: 184-189 .
7.
Sugiwama Y , Yamamoto T . Characterization of serum anti-phospholipid antibodies in patients with multiple sclerosis . Tohoku J Exp Med1996; 178: 213-215 .
8.
Harada T , Ohashi T , Fukazawa T et al. Visual function in patients with optic neuritis associated with acute transverse myelopathy in multiple sclerosis . Jap J Ophthal1993; 39: 290-294 .
9.
Alarcon-Segovia D , Deleze M , Oria CV et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients . Medicine1989; 68: 353-365 .